ZYBT — Zhengye Biotechnology Holding Cashflow Statement
0.000.00%
Last trade - 00:00- $9.53m
- $21.25m
- CNY116.36m
Annual cashflow statement for Zhengye Biotechnology Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 46.5 | 55.7 | 37.5 | 13.5 | -83 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 3.55 | 10.9 | 6.72 | 3.47 | 14.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -33.7 | -66.8 | -20.5 | -0.977 | 44.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 31.8 | 17.3 | 48.2 | 41 | 13.3 |
| Capital Expenditures | -26.4 | -27.3 | -11.6 | -27.8 | -12.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.128 | 0 | -0.165 | 0.108 | 0 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26.3 | -27.3 | -11.8 | -27.7 | -12.6 |
| Financing Cash Flow Items | 0 | 0 | -4.5 | -3.37 | 1.32 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.05 | 13.5 | -19 | -22.1 | 32.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.49 | 3.46 | 17.4 | -8.58 | 31.7 |